Ichthyosis - 33 Studies Found
| Recruiting |
: Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy : Soft Tissue Sarcoma, Adult, Stage II : 2017-04-17 : Drug: Apatinib Apatinib 500 mg is administered orally daily, until disease progression or untolerable to |
| NOT_YET_RECRUITING |
: Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) : Autosomal Recessive Ichthyosis : 2024-11-21 : Replication-defective, non-integrating HSV-1 vector expressing TGM1 formulated as a topical gel |
| COMPLETED |
: An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses : Ichthyosis : 2024-11-21 : Each subject will receive ustekinumab at Baseline (Day 0) and Months 1, 3, 5, 7, 9, and 11.During the LTE, subjects will receive injections ever |